Startup gobbles up $60M from high-profile investors to target food allergies By: San Francisco Business Times via Business Journals February 20, 2020 at 17:43 PM EST The company emerges within weeks of Aimmune Therapeutics Inc. winning the first FDA approval of a peanut allergy treatment. Read More >>